Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Pfeffer

Neurology Miami, FL Medical Doctor

NPI 1467532093 CMS profile 1382175

7100 Sw 47Th St, Miami, FL 33126

Open in the dashboard

General payments

$6,046

54 records reported · program years 2019–2025

Research payments

$167,835

Paid to them · 43 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$24,473,691 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Michael Pfeffer of Miami, FL is reported in the CMS Open Payments database as having received $6,046 across 54 general payments and $167,835 in research payments paid to them. Separately, studies naming them as principal investigator received $24,473,691 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $1,368 7
2024 General $2,451 20
2023 General $1,830 12
2023 Research $74,098 19
2022 General $325 10
2022 Research $90,435 8
2021 Research $289 1
2020 Research $1,457 5
2019 General $1,441 12
2019 Research $188 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Pfeffer
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Michael Pfeffer were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Michael Pfeffer Neurology median Middle half National median
2019 $1,441 $474 $118–$2,177 $163
2020 $0 $367 $82–$2,309 $114
2021 $0 $438 $104–$2,547 $132
2022 $325 $442 $103–$2,388 $149
2023 $1,830 $464 $119–$2,312 $160
2024 $2,451 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sage Therapeutics, Inc. $1,745 11 payments
  2. E.R. Squibb & Sons, L.L.C. $1,663 17 payments
  3. Eisai Inc. $1,311 20 payments
  4. Idorsia Pharmaceuticals US Inc $787 3 payments
  5. Grifols Biologicals LLC $455 2 payments
  6. Gilead Sciences, Inc. $85 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,420 21 payments
  2. Food and Beverage $1,627 33 payments
Products named General payments · program years 2019–2025
  1. CENERIMOD $787 3 payments
  2. Albutein $455 2 payments
  3. Flebogamma DIF $455 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Janssen Research & Development, LLC $162,257 14 payments
  2. Eli Lilly and Company $1,806 3 payments
  3. Otsuka Pharmaceutical Development & Commercialization, Inc. $1,645 8 payments
  4. AbbVie, Inc. $1,368 7 payments
  5. Teva Pharmaceuticals USA, Inc. $760 11 payments

Records

97 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record